Judge dismisses Lousiana's Rezulin suit

Hear that sigh of relief from Pfizer? A New York judge tossed out a lawsuit pitting the State of Louisiana against Pfizer over the diabetes drug Rezulin, which was pulled from the market in 2000 because of liver toxicity problems.

Louisiana was trying to recover Medicaid payments for the drug and the costs of treating illnesses Rezulin caused. And it's only one of many lawsuits filed in the wake of the drug's withdrawal. Pfizer acquired the lawsuits in its buyout of Warner-Lambert; it settled many of the personal injury claims in 2003.

- see the Trading Markets report

Related Articles:
Supreme Court to hear Pfizer liability case. Report
A look inside Pfizer's biotech center. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.